These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3840580)
1. [Relief of experimental cerebral vasospasm by the intrathecal administration of a calcium antagonist (diltiazem)--in comparison with intra-arterial administration]. Fukuoka H; Takagi T; Nagai H; Hotta K; Fujimoto S; Naitoh K No Shinkei Geka; 1985 Aug; 13(8):839-43. PubMed ID: 3840580 [TBL] [Abstract][Full Text] [Related]
2. [Effect of diltiazem on experimental cerebral vasospasm incomparison with effects of cinnarizine, verapamil and nifedipine]. Takagi T; Fukuoka H; Kamiya K; Nagai H; Hotta K No Shinkei Geka; 1983 Jun; 11(6):605-11. PubMed ID: 6621784 [TBL] [Abstract][Full Text] [Related]
3. [Experimental studies of the effect of diltiazem (Ca-antagonist) on cerebral circulation and cerebral arterial spasm]. Kyoi K; Yokoyama K; Tsukamoto M; Morimoto T; Sakaki T; Kinugawa K; Okazaki A; Utsumi S No To Shinkei; 1982 Dec; 34(12):1145-51. PubMed ID: 7159544 [TBL] [Abstract][Full Text] [Related]
4. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
5. Penetration into and elimination from the cerebrospinal fluid of diltiazem, a calcium antagonist, in anesthetized rabbits. Naito K; Nagao T; Otsuka M; Harigaya S; Nakajima H Arzneimittelforschung; 1986; 36(1):25-8. PubMed ID: 3954820 [TBL] [Abstract][Full Text] [Related]
6. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Voldby B; Petersen OF; Buhl M; Jakobsen P; Ostergaard R Acta Neurochir (Wien); 1984; 70(3-4):243-54. PubMed ID: 6546832 [TBL] [Abstract][Full Text] [Related]
7. [Effect of intravenous administration of diltiazem on cerebral blood flow and brain function]. Konishi T; Handa H; Moritake K; Suwa H; Takaya M; Takebe Y No To Shinkei; 1985 Jun; 37(6):567-73. PubMed ID: 4041287 [TBL] [Abstract][Full Text] [Related]
8. [Hydrocortisone for the treatment of cerebral vasopasm--(1) experiments in dogs (author's transl)]. Hashi K; Ohkawa N; Tanaka K; Nakamura T; Nishimura S No Shinkei Geka; 1978 Jan; 6(1):49-57. PubMed ID: 580108 [TBL] [Abstract][Full Text] [Related]
9. Cerebral vasodilating and spasmolytic actions of a new Ca-antagonist, clentiazem (TA-3090), in anesthetized animals. Murata S; Kikkawa K; Nagao T J Cardiovasc Pharmacol; 1992 May; 19(5):790-7. PubMed ID: 1381778 [TBL] [Abstract][Full Text] [Related]
10. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats. Tanaka K; Gotoh F; Muramatsu F; Fukuuchi Y; Okayasu H; Suzuki N; Kobari M Arzneimittelforschung; 1982; 32(12):1529-34. PubMed ID: 6891592 [TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
13. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm. Cirak B; Kiymaz N; Ari HH; Ugras S Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650 [TBL] [Abstract][Full Text] [Related]
14. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. McGirt MJ; Pradilla G; Legnani FG; Thai QA; Recinos PF; Tamargo RJ; Clatterbuck RE Neurosurgery; 2006 May; 58(5):945-51; discussion 945-51. PubMed ID: 16639331 [TBL] [Abstract][Full Text] [Related]